Health systems are rapidly testing out and scaling ambient AI tools to help clinicians with tedious documentation. This shift to AI for medical notetaking is propelling Abridge to new heights.
The generative AI startup banked $250 million in series D funding co-led by Elad Gil and IVP. Investors Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures, which is NVIDIA’s venture capital arm, Redpoint Ventures, Spark Capital and SV Angel also contributed to the raise.
Abridge's technology has now been deployed in more than 100 health systems, including newly announced Akron Children’s, Endeavor Health, Inova, Memorial Sloan Kettering Cancer Center and Oak Street Health, owned by CVS Health, the company announced Monday.
Within the last eight weeks, Abridge has also announced enterprisewide implementations at Duke Health, Johns Hopkins, the Mayo Clinic and UNC Health, representing tens of thousands of clinicians.
Abridge is now valued at $2.75 billion post-money, Forbes reported Monday.
The series D raise comes a year after the Pittsburgh-based startup picked up $150 million series C funding round to invest in more research and development to build bedrock foundation models.
Abridge plans to use the hefty $250 million investment to develop additional AI capabilities and to fuel commercial growth to support broader applications, executives said.
The seven-year-old company, which is exhibiting at the ViVE 2025 conference this week in Nashville, also unveiled a new AI tool to streamline clinical and financial workflows at the point of care. The tool was designed to tackle problems with incomplete clinical notes that delay billing processes. Abridge developed what it has dubbed a "contextual reasoning engine" that produces billable notes that support appropriate claims at the point of care, executives said in a press release.
"The Abridge Contextual Reasoning Engine helps us concentrate more value into our core documentation offering, integrating system and revenue cycle requirements into a sophisticated and orchestrated system of AI models,” Shiv Rao, M.D., Abridge CEO and founder, said in a statement. “We aspire to serve our health system partners for the decades to come. This investment supports that aspiration, as well as the core research and development that differentiates our approach.”
Tanner Health, a healthcare provider in west Georgia and east Alabama, is now using Abridge’s AI platform for clinical conversations enterpris-ewide, with an initial focus on behavioral health clinicians.
“The impact of Abridge on clinicians has been even better than I expected,” Bonnie Boles, M.D., Tanner’s chief medical information officer, said in a statement. “A busy primary care doctor reported that this is the first time in 30 years she is finishing her notes by the end of clinic. A surgeon told me that he used to spend 4-5 hours at the end of every day to finish documentation—now he’s done in an hour.”
Several health systems are moving forward with wide-scale implementations of Abridge's technology. Johns Hopkins Medicine is rolling out Abridge’s ambient AI platform across its 6,700 clinicians, six hospitals and 40 patient-care centers. About six months after announcing an initiative to focus on nursing documentation workflows, Mayo Clinic is now expanding the use of Abridge's AI platform enterprisewide, starting with about 2,000 clinicians.
Following a pilot, the Deaconess Health System also is expanding use of the ambient AI tech across its 19-hospital network.
The company also continues to develop new gen AI products to suit the needs of specific clinicians. The company launched a new gen AI product for emergency care, and it's currently in use at several health systems including the Deaconess Health System, Emory Healthcare, Johns Hopkins Medicine and UChicago Medicine.